Comprehensive prediction of drug-protein interactions and side effects for the human proteome

The Nature of Statistical Learning Theory

Vapnik, V. N. (1995) · doi:10.1007/978-1-4757-2440-0 · Cited by 39,138 · see citing works

The protein data bank: A computer-based archival file for macromolecular structures

Bernstein, F. C., Koetzle, T. F., Williams, G. J. B., Meyer, E. F., Brice, M. D., Rodgers, J. R., Kennard, O., Shimanouchi, T., & Tasumi, M. (1977) · Journal of Molecular Biology · doi:10.1016/s0022-2836(77)80200-3 · Cited by 8,582 · see citing works

A map of human genome variation from population-scale sequencing.

The 1000 Genomes Project Consortium (2010) · Nature · doi:10.1038/nature09534 · Cited by 7,877 · see citing works

Amino acid substitution matrices from protein blocks.

Henikoff, S., & Henikoff, J. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10915 · Cited by 6,218 · see citing works

ChEMBL: a large-scale bioactivity database for drug discovery

Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382 · see citing works

DrugBank: a comprehensive resource for in silico drug discovery and exploration

Wishart, D. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj067 · Cited by 3,892 · see citing works

Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking.

Mysinger, M. M., Carchia, M., Irwin, J. J., & Shoichet, B. K. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300687e · Cited by 2,412 · see citing works

Scoring function for automated assessment of protein structure template quality

Zhang, Y., & Skolnick, J. (2004) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.20264 · Cited by 2,392 · see citing works

Predicting new molecular targets for known drugs

Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., et al. (2009) · Nature · doi:10.1038/nature08506 · Cited by 1,667 · see citing works

Benchmarking sets for molecular docking.

Huang, N., Shoichet, B. K., & Irwin, J. J. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0608356 · Cited by 1,318 · see citing works

Drug target identification using side-effect similarity

Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J., & Bork, P. (2008) · Science · doi:10.1126/science.1158140 · Cited by 1,248 · see citing works

Prediction of drug–target interaction networks from the integration of chemical and genomic spaces

Yamanishi, Y., Araki, M., Gutteridge, A., Honda, W., & Kanehisa, M. I. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn162 · Cited by 1,148 · see citing works

How significant is a protein structure similarity with TM-score = 0.5?

Xu, J., & Zhang, Y. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq066 · Cited by 1,142 · see citing works

A machine learning approach to predicting protein–ligand binding affinity with applications to molecular docking

Ballester, P. J., & Mitchell, J. B. O. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq112 · Cited by 988 · see citing works

Gaussian interaction profile kernels for predicting drug–target interaction

van Laarhoven, T., Nabuurs, S. B., & Marchiori, E. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr500 · Cited by 935 · see citing works

A side effect resource to capture phenotypic effects of drugs

Kuhn, M., Campillos, M., Letunic, I., Jensen, L. J., & Bork, P. (2010) · Molecular Systems Biology · doi:10.1038/msb.2009.98 · Cited by 899 · see citing works

PREDICT: a method for inferring novel drug indications with application to personalized medicine

Gottlieb, A., Stein, G. Y., Ruppin, E., & Sharan, R. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.26 · Cited by 892 · see citing works

Large-scale prediction and testing of drug activity on side-effect targets

Lounkine, E., Keiser, M. J., Whitebread, S., Mikhailov, D., Hamon, J., Jenkins, J. L., Lavan, P., Weber, E., Doak, A. K., Côté, S., et al. (2012) · Nature · doi:10.1038/nature11159 · Cited by 879 · see citing works

A Computer Program for Classifying Plants

Rogers, D. J., & Tanimoto, T. T. (1960) · Science · doi:10.1126/science.132.3434.1115 · Cited by 874 · see citing works

Similarity-based virtual screening using 2D fingerprints

Willett, P. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.005 · Cited by 849 · see citing works

Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference

Cheng, F., Liu, C., Jiang, J., Lü, W., Li, W., Liu, G., Zhou, W., Huang, J. Y., & Tang, Y. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002503 · Cited by 820 · see citing works

Global mapping of pharmacological space

Paolini, G. V., Shapland, R. H. B., van Hoorn, W. P., Mason, J. S., & Hopkins, A. L. (2006) · Nature Biotechnology · doi:10.1038/nbt1228 · Cited by 812 · see citing works

Molecular Similarity in Medicinal Chemistry

Maggiora, G. M., Vogt, M., Stumpfe, D., & Bajorath, J. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401411z · Cited by 669 · see citing works

Supervised prediction of drug–target interactions using bipartite local models

Kevin Bleakley, A., & Yamanishi, Y. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp433 · Cited by 631 · see citing works

Neighborhood Behavior: A Useful Concept for Validation of “Molecular Diversity” Descriptors

Patterson, D. E., CRAMER, R. D. I., Ferguson, A. M., Clark, R. D., & Weinberger, L. E. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960290n · Cited by 509 · see citing works

STITCH 4: integration of protein–chemical interactions with user data

Kuhn, M., Szklarczyk, D., Pletscher-Frankild, S., Blicher, T. H., von Mering, C., Jensen, L. J., & Peer Bork, B. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1207 · Cited by 487 · see citing works

Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework

Yamanishi, Y., Kotera, M., Kanehisa, M. I., & Goto, S. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq176 · Cited by 472 · see citing works

SPICKER: A clustering approach to identify near‐native protein folds

Zhang, Y., & Skolnick, J. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20011 · Cited by 393 · see citing works

Drug–target interaction prediction by learning from local information and neighbors

Mei, J.-P., Kwoh, C.-K., Yang, P., Li, X., & Zheng, J. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts670 · Cited by 384 · see citing works

Computational Drug Repositioning: From Data to Therapeutics

Hurle, M. R., Yang, L., Xie, Q. S., Rajpal, D. K., Sanséau, P., & Agarwal, P. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.1 · Cited by 375 · see citing works

Automated structure prediction of weakly homologous proteins on a genomic scale

Zhang, Y., & Skolnick, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305695101 · Cited by 344 · see citing works

A threading-based method (FINDSITE) for ligand-binding site prediction and functional annotation

Brylinski, M., & Skolnick, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707684105 · Cited by 333 · see citing works

Drug Discovery Using Chemical Systems Biology: Repositioning the Safe Medicine Comtan to Treat Multi-Drug and Extensively Drug Resistant Tuberculosis

Kinnings, S., Liu, N., Buchmeier, N. A., Tonge, P. J., Xie, L., & Bourne, P. E. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000423 · Cited by 318 · see citing works

Drug repositioning for personalized medicine

Li, Y. Y., & Jones, S. J. M. (2012) · Genome Medicine · doi:10.1186/gm326 · Cited by 250 · see citing works

Predicting Drug-Target Interactions for New Drug Compounds Using a Weighted Nearest Neighbor Profile

van Laarhoven, T., & Marchiori, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066952 · Cited by 246 · see citing works

PROMISCUOUS: a database for network-based drug-repositioning

von Eichborn, J., Murgueitio, M. S., Dunkel, M., Koerner, S., Bourne, P. E., & Preißner, R. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq1037 · Cited by 225 · see citing works

DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical–protein interactome

Luo, H., Chen, J., Shi, L., Mikailov, M., Zhu, H., Wang, K., He, L., & Yang, L. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr299 · Cited by 206 · see citing works

Predicting Drug–Target Interactions Using Probabilistic Matrix Factorization

Çobanoğlu, M. C., Liu, C., Hu, F., Oltvai, Z. N., & Bahar, İ. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400219z · Cited by 187 · see citing works

Repurposing Strategies for Therapeutics

Sleigh, S. H., & Barton, C. L. (2010) · Pharmaceutical Medicine · doi:10.1007/bf03256811 · Cited by 167 · see citing works

Assessment of programs for ligand binding affinity prediction

Kim, R., & Skolnick, J. (2008) · Journal of Computational Chemistry · doi:10.1002/jcc.20893 · Cited by 149 · see citing works

Drug Side-Effect Prediction Based on the Integration of Chemical and Biological Spaces

Yamanishi, Y., Pauwels, E., & Kotera, M. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci2005548 · Cited by 144 · see citing works

A Comprehensive Survey of Small-Molecule Binding Pockets in Proteins

Gao, M., & Skolnick, J. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003302 · Cited by 142 · see citing works

Fr-TM-align: a new protein structural alignment method based on fragment alignments and the TM-score

Pandit, S. B., & Skolnick, J. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-531 · Cited by 138 · see citing works

APoc: large-scale identification of similar protein pockets

Gao, M., & Skolnick, J. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt024 · Cited by 125 · see citing works

Systematic identification of proteins that elicit drug side effects

Kuhn, M., Banchaabouchi, M. A., Campillos, M., Jensen, L. J., Gross, C. T., Gavin, A., & Peer Bork, B. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.10 · Cited by 117 · see citing works

The distribution of ligand-binding pockets around protein-protein interfaces suggests a general mechanism for pocket formation

Gao, M., & Skolnick, J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117768109 · Cited by 99 · see citing works

FINDSITELHM: A Threading-Based Approach to Ligand Homology Modeling

Bryliński, M., & Skolnick, J. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000405 · Cited by 78 · see citing works

Database identifies FDA-approved drugs with potential to be repurposed for treatment of orphan diseases

Xu, K., & Coté, T. R. (2011) · Briefings in Bioinformatics · doi:10.1093/bib/bbr006 · Cited by 71 · see citing works

FINDSITE comb : A Threading/Structure-Based, Proteomic-Scale Virtual Ligand Screening Approach

Zhou, H., & Skolnick, J. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300510n · Cited by 63 · see citing works

Interplay of physics and evolution in the likely origin of protein biochemical function

Skolnick, J., & Gao, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300011110 · Cited by 62 · see citing works

Cheminformatic/bioinformatic analysis of large corporate databases: Application to drug repurposing

Loging, W., Rodriguez‐Esteban, R., Hill, J., Freeman, T. C., & Miglietta, J. J. (2011) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2011.06.004 · Cited by 50 · see citing works

FINDSITEX: A Structure-Based, Small Molecule Virtual Screening Approach with Application to All Identified Human GPCRs

Zhou, H., & Skolnick, J. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3000716 · Cited by 36 · see citing works

Inferring protein domains associated with drug side effects based on drug-target interaction network

Iwata, H., Mizutani, S., Tabei, Y., Kotera, M., Goto, S., & Yamanishi, Y. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-s6-s18 · Cited by 29 · see citing works

Three-dimensional model of the SHBG-like region of anticoagulant protein S: New structure-function insights

Villoutreix, B. O., Dahlb�ck, B., Borgel, D., Gandrille, S., & Muller, Y. A. (2001) · Proteins Structure Function and Bioinformatics · doi:10.1002/1097-0134(20010501)43:2 · Cited by 26 · see citing works

Experimental validation of FINDSITEcomb virtual ligand screening results for eight proteins yields novel nanomolar and micromolar binders

Srinivasan, B., Zhou, H., Kubanek, J., & Skolnick, J. (2014) · Journal of Cheminformatics · doi:10.1186/1758-2946-6-16 · Cited by 26 · see citing works

Project ranks billions of drug interactions

Reardon, S. (2013) · Nature · doi:10.1038/503449a · Cited by 20 · see citing works

Contrast agents and mechanisms

Dastrù, W., Longo, D. L., & Aime, S. (2011) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2011.11.013 · Cited by 16 · see citing works

Polynucleotide secondary structures: an historical perspective

Arnott, S. (1999) · doi:10.1093/oso/9780198500384.003.0001 · Cited by 13 · see citing works

STITCH 5: augmenting protein–chemical interaction networks with tissue and affinity data

Szklarczyk, D., Santos, A., von Mering, C., Jensen, L. J., Peer Bork, B., & Kuhn, M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1277 · Cited by 1,702 · see citing works

Machine Learning in Drug Discovery: A Review

Dara, S., Dhamercherla, S., Jadav, S. S., Babu, C. M., & Ahsan, M. J. (2021) · Artificial Intelligence Review · doi:10.1007/s10462-021-10058-4 · Cited by 843 · see citing works

Drug repurposing from the perspective of pharmaceutical companies

Cha, Y., Erez, T., Reynolds, I. J., Kumar, D., Ross, J., Koytiger, G., Kusko, R. L., Zeskind, B. J., Risso, S., Kagan, E., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13798 · Cited by 434 · see citing works

In silico methods for drug repurposing and pharmacology

Hodos, R. A., Kidd, B. A., Shameer, K., Readhead, B., & Dudley, J. T. (2016) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1337 · Cited by 333 · see citing works

Utilizing graph machine learning within drug discovery and development

Gaudelet, T., Day, B., Jamasb, A. R., Soman, J., Regep, C., Liu, G., Hayter, J. B. R., Vickers, R., Roberts, C., Tang, J., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab159 · Cited by 313 · see citing works

AlphaFold 2: Why It Works and Its Implications for Understanding the Relationships of Protein Sequence, Structure, and Function

Skolnick, J., Gao, M., Zhou, H., & Singh, S. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c01114 · Cited by 251 · see citing works

Artificial Intelligence for COVID-19 Drug Discovery and Vaccine Development

Arshadi, A. K., Webb, J., Salem, M., Cruz, E., Calad-Thomson, S., Ghadirian, N., Collins, J., Diez‐Cecilia, E., Kelly, B., Goodarzi, H., et al. (2020) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2020.00065 · Cited by 245 · see citing works

Changing Trends in Computational Drug Repositioning

Yella, J., Yaddanapudi, S., Wang, Y., & Jegga, A. G. (2018) · Pharmaceuticals · doi:10.3390/ph11020057 · Cited by 166 · see citing works

Link prediction in drug-target interactions network using similarity indices

Lu, Y., Guo, Y., & Korhonen, A. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1460-z · Cited by 116 · see citing works

Phenotypes associated with genes encoding drug targets are predictive of clinical trial side effects

Nguyen, P. A., Born, D. A., Deaton, A. M., Nioi, P., & Ward, L. D. (2019) · Nature Communications · doi:10.1038/s41467-019-09407-3 · Cited by 104 · see citing works

Harnessing machine learning for development of microbiome therapeutics

McCoubrey, L. E., Elbadawi, M., Orlu, M., Gaisford, S., & Basit, A. W. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1872323 · Cited by 94 · see citing works

Validation strategies for target prediction methods

Mathai, N., Chen, Y., & Kirchmair, J. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz026 · Cited by 86 · see citing works

An up-to-date overview of computational polypharmacology in modern drug discovery

Chaudhari, R. R., Fong, L. W. R., Tan, Z., Huang, B., & Zhang, S. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1767063 · Cited by 83 · see citing works

A brief review of protein–ligand interaction prediction

Zhao, L., Zhu, Y. L., Wang, J., Wen, N., Wang, C., & Cheng, L. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.06.004 · Cited by 61 · see citing works

Structure-based prediction of ligand–protein interactions on a genome-wide scale

Hwang, H., Dey, F., Petrey, D. S., & Honig, B. H. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705381114 · Cited by 60 · see citing works

Structural coverage of the proteome for pharmaceutical applications

Somody, J. C., MacKinnon, S. S., & Windemuth, A. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.08.004 · Cited by 59 · see citing works

Web-based drug repurposing tools: a survey

Sam, E., & Athri, P. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx125 · Cited by 58 · see citing works

A knowledge-based approach for predicting gene–disease associations

Zhou, H., & Skolnick, J. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw358 · Cited by 55 · see citing works

Screening drug-target interactions with positive-unlabeled learning

Peng, L., Zhu, W. Q., Liao, B., Yu, D., Chen, M., Chen, Y., & Yang, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-08079-7 · Cited by 55 · see citing works

Improving drug safety: From adverse drug reaction knowledge discovery to clinical implementation

Tan, Y., Hu, Y. Q., Liu, X., Yin, Z., Chen, X.-W., & Liu, M. (2016) · Methods · doi:10.1016/j.ymeth.2016.07.023 · Cited by 50 · see citing works

Survey of Similarity-Based Prediction of Drug-Protein Interactions

Wang, C., & Kurgan, L. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190808154841 · Cited by 49 · see citing works

Repurposing FDA-approved drugs for anti-aging therapies

Snell, T. W., Johnston, R. K., Srinivasan, B., Zhou, H., Gao, M., & Skolnick, J. (2016) · Biogerontology · doi:10.1007/s10522-016-9660-x · Cited by 47 · see citing works

A comprehensive review of computational techniques for the prediction of drug side effects

Sachdev, K., & Gupta, M. K. (2020) · Drug Development Research · doi:10.1002/ddr.21669 · Cited by 45 · see citing works

The Promise and Peril of Chemical Probe Negative Controls

Lee, J.-Y., & Schapira, M. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00036 · Cited by 44 · see citing works

DeepSide: A Deep Learning Approach for Drug Side Effect Prediction

Uner, O. C., Kuru, H. İ., Cinbiş, R. G., Taştan, Ö., & Çiçek, A. E. (2022) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2022.3141103 · Cited by 43 · see citing works

Machine learning prediction of side effects for drugs in clinical trials

Galeano, D., & Paccanaro, A. (2022) · Cell Reports Methods · doi:10.1016/j.crmeth.2022.100358 · Cited by 43 · see citing works

A Survey on Computational Methods in Drug Discovery for Neurodegenerative Diseases

Vicidomini, C., Fontanella, F., D’Alessandro, T., & Roviello, G. N. (2024) · Biomolecules · doi:10.3390/biom14101330 · Cited by 43 · see citing works

Systematic literature review reveals suboptimal use of chemical probes in cell-based biomedical research

Sterling, J., Baker, J. R., McCluskey, A., & Munoz, L. (2023) · Nature Communications · doi:10.1038/s41467-023-38952-1 · Cited by 40 · see citing works

Detecting similar binding pockets to enable systems polypharmacology

Duran‐Frigola, M., Siragusa, L., Ruppin, E., Barril, X., Cruciani, G., & Aloy, P. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005522 · Cited by 40 · see citing works

FINDSITE^comb2.0: A New Approach for Virtual Ligand Screening of Proteins and Virtual Target Screening of Biomolecules

Zhou, H., Cao, H., & Skolnick, J. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00309 · Cited by 39 · see citing works

MEDICASCY: A Machine Learning Approach for Predicting Small-Molecule Drug Side Effects, Indications, Efficacy, and Modes of Action

Zhou, H., Cao, H., Matyunina, L., Shelby, M., Cassels, L., McDonald, J. F., & Skolnick, J. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01248 · Cited by 39 · see citing works

Gains from no real PAINS: Where ‘Fair Trial Strategy’ stands in the development of multi-target ligands

Sun, J., Zhong, H., Wang, K., Li, N., & Chen, L. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.02.023 · Cited by 36 · see citing works

Methods for Discovering and Targeting Druggable Protein-Protein Interfaces and Their Application to Repurposing

Özdemir, E. S., Halakou, F., Nussinov, R., Gürsoy, A., & Keskin, Ö. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8955-3_1 · Cited by 34 · see citing works

Targeted in vivo delivery of EGFR siRNA inhibits ovarian cancer growth and enhances drug sensitivity

Satpathy, M., Mezencev, R., Wang, L., & McDonald, J. F. (2016) · Scientific Reports · doi:10.1038/srep36518 · Cited by 32 · see citing works

Are protein-protein interfaces special regions on a protein’s surface?

Tonddast-Navaei, S., & Skolnick, J. (2015) · The Journal of Chemical Physics · doi:10.1063/1.4937428 · Cited by 31 · see citing works

Machine Learning Classification Models to Improve the Docking‐based Screening: A Case of PI3K‐Tankyrase Inhibitors

Berishvili, V. P., Voronkov, A. E., Radchenko, E. V., & Palyulin, V. A. (2018) · Molecular Informatics · doi:10.1002/minf.201800030 · Cited by 31 · see citing works

Combined pharmacophore modeling, 3D-QSAR and docking studies to identify novel HDAC inhibitors using drug repurposing

Liu, J., Zhu, Y., He, Y., Zhu, H., Gao, Y. Q., Li, Z., Zhu, J., Sun, X., Fang, F., Wen, H., et al. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1590241 · Cited by 30 · see citing works

DeepSide: a deep learning approach for drug side effect prediction

Üner, O. C., Kuru, H. İ., Cinbiş, R. G., Taştan, Ö., & Cicek, E. (2023) · Sabanci University · Cited by 28 · see citing works

Effect of Dimethyl Sulfoxide on the Binding of 1-Adamantane Carboxylic Acid to β- and γ-Cyclodextrins

Senac, C., Desgranges, S., Contino-Pepin, C., Urbach, W., Fuchs, P., & Taulier, N. (2018) · ACS Omega · doi:10.1021/acsomega.7b01212 · Cited by 28 · see citing works

Identifying Potential Ageing-Modulating Drugs In Silico

Dönertaş, H. M., Fuentealba, M., Partridge, L., & Thornton, J. M. (2018) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2018.11.005 · Cited by 28 · see citing works

Using Drug Similarities for Discovery of Possible Adverse Reactions

Muñoz, E., Nováček, V., & Vandenbussche, P.-Y. (2016) · PubMed Central · doi:10.13025/21076 · Cited by 26 · see citing works

DeepSide: A Deep Learning Framework for Drug Side Effect PredictionPreprint

Üner, O. C., Cinbiş, R. G., Taştan, Ö., & Çiçek, A. E. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/843029 · Cited by 26 · see citing works

Rational drug repurposing for cancer by inclusion of the unbiased molecular dynamics simulation in the structure-based virtual screening approach: Challenges and breakthroughs

Sohraby, F., & Aryapour, H. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.04.007 · Cited by 25 · see citing works

cando.py: Open Source Software for Predictive Bioanalytics of Large Scale Drug–Protein–Disease Data

Mangione, W., Falls, Z., Chopra, G., & Samudrala, R. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00110 · Cited by 25 · see citing works

Repurposed FDA-approved drugs targeting genes influencing aging can extend lifespan and healthspan in rotifers

Snell, T. W., Johnston, R. K., Matthews, A. B., Zhou, H., Gao, M., & Skolnick, J. (2018) · Biogerontology · doi:10.1007/s10522-018-9745-9 · Cited by 23 · see citing works

Multiscale modelling of drug mechanism and safety

Zhang, J. D., Sach-Peltason, L., Krämer, C., Wang, K., & Ebeling, M. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.12.009 · Cited by 22 · see citing works

Computational Identification of Stearic Acid as a Potential PDK1 Inhibitor and In Vitro Validation of Stearic Acid as Colon Cancer Therapeutic in Combination with 5-Fluorouracil

Mitchel, J., Bajaj, P., Patil, K., Gunnarson, A., Pourchet, E., Kim, Y. N., Skolnick, J., & Pai, S. B. (2021) · Cancer Informatics · doi:10.1177/11769351211065979 · Cited by 21 · see citing works

PathFX provides mechanistic insights into drug efficacy and safety for regulatory review and therapeutic development

Wilson, J. L., Racz, R., Liu, T., Adeniyi, O., Sun, J., Ramamoorthy, A., Pacanowski, M. A., & Altman, R. B. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006614 · Cited by 19 · see citing works

CoDe-DTI: Collaborative Deep Learning-based Drug-Target Interaction Prediction

Yasuo, N., Nakashima, Y., & Sekijima, M. (2018) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2018.8621368 · Cited by 18 · see citing works

Future Directions of Pharmacovigilance Studies Using Electronic Medical Recording and Human Genetic Databases

Choi, Y. H., Han, C. Y., Kim, K. S., & Kim, S. G. (2019) · Toxicological Research · doi:10.5487/tr.2019.35.4.319 · Cited by 16 · see citing works

Drug‐Target Interaction Prediction Based on Adversarial Bayesian Personalized Ranking

Ye, Y., Wen, Y., Zhang, Z., He, S., & Bo, X. (2021) · BioMed Research International · doi:10.1155/2021/6690154 · Cited by 16 · see citing works

Thermal Reversibility and Structural Stability in Lysozyme Induced by Epirubicin Hydrochloride

Khamari, L., Pramanik, U., Shekhar, S., Mohanakumar, S., & Mukherjee, S. (2021) · Langmuir · doi:10.1021/acs.langmuir.1c00179 · Cited by 16 · see citing works

Recycled Translation: Repurposing Drugs for Stroke

Spellicy, S. E., & Hess, D. C. (2022) · Translational Stroke Research · doi:10.1007/s12975-022-01000-z · Cited by 15 · see citing works

FOTF-CPI: A compound-protein interaction prediction transformer based on the fusion of optimal transport fragments

Yin, Z., Chen, Y., Hao, Y., Pandiyan, S., Shao, J., & Wang, L. (2023) · iScience · doi:10.1016/j.isci.2023.108756 · Cited by 16 · see citing works

Identifying potential natural inhibitors of Brucella melitensis Methionyl-tRNA synthetase through an in-silico approach

Rowaiye, A. B., Ogugua, A. J., Ibeanu, G. C., Bur, D., Asala, T., Ogbeide, O. B., Abraham, E. O., & Usman, H. B. (2022) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0009799 · Cited by 15 · see citing works

Proteome‐Scale Drug‐Target Interaction Predictions: Approaches and Applications

MacKinnon, S. S., Tonekaboni, S. A. M., & Windemuth, A. (2021) · Current Protocols · doi:10.1002/cpz1.302 · Cited by 13 · see citing works

Why Is There a Glass Ceiling for Threading Based Protein Structure Prediction Methods?

Skolnick, J., & Zhou, H. (2016) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.6b09517 · Cited by 14 · see citing works

In Silico Databases and Tools for Drug Repurposing

Serçinoğlu, O., & Özbek, P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00024-9 · Cited by 14 · see citing works

Dual Representation Learning for Predicting Drug-Side Effect Frequency Using Protein Target Information

Park, S., Lee, S., Pak, M., & Kim, S. (2024) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2024.3350083 · Cited by 13 · see citing works

High Impact: The Role of Promiscuous Binding Sites in Polypharmacology

Cerisier, N., Petitjean, M., Regad, L., Bayard, Q., Réau, M. F., Badel, A., & Camproux, A. (2019) · Molecules · doi:10.3390/molecules24142529 · Cited by 13 · see citing works

PolypharmDB, a Deep Learning-Based Resource, Quickly Identifies Repurposed Drug Candidates for COVID-19Preprint

Redka, D. S., MacKinnon, S. S., Landon, M. R., Windemuth, A., Kurji, N., & Shahani, V. M. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12071271.v1 · Cited by 13 · see citing works

On the importance of composite protein multiple ligand interactions in protein pockets

Tonddast‐Navaei, S., Srinivasan, B., & Skolnick, J. (2016) · Journal of Computational Chemistry · doi:10.1002/jcc.24523 · Cited by 12 · see citing works

In silico systems for predicting chemical-induced side effects using known and potential chemical protein interactions, enabling mechanism estimation

Amano, Y., Honda, H., Sawada, R., Nukada, Y., Yamane, M., Ikeda, N., Morita, O., & Yamanishi, Y. (2020) · The Journal of Toxicological Sciences · doi:10.2131/jts.45.137 · Cited by 12 · see citing works

Evaluating molecular fingerprint-based models of drug side effects against a statistical control

Alpay, B. A., Gosink, M. M., & Aguiar, D. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103364 · Cited by 12 · see citing works

Utilising Graph Machine Learning within Drug Discovery and DevelopmentPreprint

Gaudelet, T., Day, B., Jamasb, A. R., Soman, J., Regep, C., Liu, G., Hayter, J. B. R., Vickers, R. J., Roberts, C., Tang, J., et al. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2012.05716 · Cited by 11 · see citing works

How special is the biochemical function of native proteins?

Skolnick, J., Gao, M., & Zhou, H. (2016) · F1000Research · doi:10.12688/f1000research.7374.1 · Cited by 10 · see citing works

Systematic Analyses and Prediction of Human Drug Side Effect Associated Proteins from the Perspective of Protein Evolution

Begum, T., Ghosh, T. C., & Basak, S. (2017) · Genome Biology and Evolution · doi:10.1093/gbe/evw301 · Cited by 10 · see citing works

An integrative approach to develop computational pipeline for drug-target interaction network analysis

Bansal, A., Srivastava, P. A., & Singh, T. R. (2018) · Scientific Reports · doi:10.1038/s41598-018-28577-6 · Cited by 10 · see citing works

Lansoprazole as a potent HDAC2 inhibitor for treatment of colorectal cancer: An in-silico analysis and experimental validation

Khadempar, S., Lotfi, M., Haghiralsadat, F., Saidijam, M., Ghasemi, N., & Afshar, S. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107518 · Cited by 9 · see citing works

Bioinformatics Perspective of Drug Repurposing

Patel, B., Gelat, B., Soni, M. N., Rathaur, P., & Johar, K. (2023) · Current Bioinformatics · doi:10.2174/0115748936264692230921071504 · Cited by 9 · see citing works

Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genes

Fisher, J. L., Clark, A. D., Jones, E. F., & Lasseigne, B. N. (2024) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-023-00727-1 · Cited by 9 · see citing works

Machine learning for predicting drug–drug interactions: Graph neural networks and beyond

Petschner, P., Nguyen, A. D., Nguyen, C. H., & Mamitsuka, H. (2025) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2025.100551 · Cited by 9 · see citing works

How has artificial intelligence impacted COVID-19 drug repurposing and what lessons have we learned?

Özdemir, E. S., Ranganathan, S. V., & Nussinov, R. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.2128333 · Cited by 9 · see citing works

Gelatin–rosin gum complex nanoparticles: preparation, characterization and colon targeted delivery of 5-fluorouracil

Joshi, S., & Singh, V. (2020) · Chemical Papers · doi:10.1007/s11696-020-01231-0 · Cited by 9 · see citing works

Binding of warfarin differently affects the thermal behavior and chain packing of anionic, zwitterionic and cationic lipid membranes

Aloi, E., Rizzuti, B., Guzzi, R., & Bartucci, R. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108599 · Cited by 9 · see citing works

Drug‐target‐ADR Network and Possible Implications of Structural Variants in Adverse Events

Dafniet, B., Cerisier, N., Audouze, K., & Taboureau, O. (2020) · Molecular Informatics · doi:10.1002/minf.202000116 · Cited by 8 · see citing works

Preclinical side effect prediction through pathway engineering of protein interaction network models

Alidoost, M., & Wilson, J. L. (2024) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.13150 · Cited by 7 · see citing works

In Silico Tools to Score and Predict Cholesterol–Protein Interactions

Nguyen, A., & Ondrus, A. E. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01885 · Cited by 8 · see citing works

Multi-Knowledge Graph and Multi-View Entity Feature Learning for Predicting Drug-Related Side Effects

Xuan, P., Cheng, T., Cui, H., Gu, J., Jin, Q., & Zhang, T. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c00136 · Cited by 8 · see citing works

Computational investigation unveils pathogenic LIG3 non-synonymous mutations and therapeutic targets in acute myeloid leukemia

Hossen, M. A., Jahan, U. M. S., Hossain, M. A., Asif, K. H., Rahman, A., Ahmed, S., Uddin, M. M., Amin, M. F., Barik, M. A., Islam, M. J., et al. (2025) · PLOS One · doi:10.1371/journal.pone.0320550 · Cited by 8 · see citing works

Cytoplasmic expression of EGFR shRNA using a modified T7 autogene-based hybrid mRNA/DNA system induces long-term EGFR silencing and prolongs antitumor effects

Seraj, S., Cho, Y., Lee, J., & Ahn, H. J. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113735 · Cited by 8 · see citing works

Repurposing FDA‐Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease

Xu, C., Zou, H., Yu, X., Xie, Y., Cai, J., Shang, Q., Ouyang, N., Wang, Y., Xu, P., He, Z., et al. (2020) · ChemistryOpen · doi:10.1002/open.202000235 · Cited by 7 · see citing works

Advanced Proteomics Approaches Hold Potential for the Risk Assessment of Metabolism-Disrupting Chemicals as Omics-Based NAM: A Case Study Using the Phthalate Substitute DINCH

Aldehoff, A. S., Karkossa, I., Broghammer, H., Krupka, S., Weiner, J., Goerdeler, C., Nuwayhid, R., Langer, S., Wabitsch, M., Rolle-Kampczyk, U. E., et al. (2025) · Environmental Science & Technology · doi:10.1021/acs.est.5c01206 · Cited by 7 · see citing works

De Novo Prediction of Drug Targets and Candidates by Chemical Similarity-Guided Network-Based Inference

Vigil-Vásquez, C., & Schüller, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179666 · Cited by 7 · see citing works

Using Machine Learning To Inform Decisions in Drug Discovery: An Industry Perspective

Green, D. V. S. (2019) · ACS symposium series · doi:10.1021/bk-2019-1326.ch005 · Cited by 7 · see citing works

Global organization of a binding site network gives insight into evolution and structure-function relationships of proteins

Lee, J., Konc, J., Janežič, D., & Brooks, B. R. (2017) · Scientific Reports · doi:10.1038/s41598-017-10412-z · Cited by 7 · see citing works

Hub nodes in the network of human Mitogen-Activated Protein Kinase (MAPK) pathways: Characteristics and potential as drug targets

Aksam, V. K. M., Chandrasekaran, V. M., & Pandurangan, S. (2017) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2017.08.006 · Cited by 6 · see citing works

Identifying Novel Drug Targets by iDTPnd: A Case Study of Kinase Inhibitors

Naveed, H., Reglin, C., Schubert, T. E. O., Gao, X., Arold, S. T., & Maitland, M. L. (2021) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2020.05.006 · Cited by 6 · see citing works

Systematic in silico Evaluation of Leishmania spp. Proteomes for Drug Discovery

Vasconcelos, C. R. D. S., & Rezende, A. M. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.607139 · Cited by 6 · see citing works

Prediction of severe adverse events, modes of action and drug treatments for COVID-19’s complications

Astore, C., Zhou, H., Jacob, J., & Skolnick, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-00368-6 · Cited by 6 · see citing works

Ubiquitin Receptor RPN13 Mediates the Inhibitory Interaction of Diphenyldihaloketones CLEFMA and EF24 With the 26S Proteasome

Rao, G., Nkepang, G. N., Xu, J., Yari, H., Houson, H. A., Teng, C., & Awasthi, V. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00392 · Cited by 6 · see citing works

Network pharmacology to elucidate the role of phytotherapy in neurocognitive disorders

Barth, S., & Efferth, T. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157031 · Cited by 6 · see citing works

Drug Dosage Balancing Using Large Scale Multi-omics Datasets

Jha, A., Mehdi, M., Khan, Y., Mehmood, Q., Rebholz‐Schuhmann, D., & Sahay, R. (2017) · Lecture notes in computer science · doi:10.1007/978-3-319-57741-8_6 · Cited by 5 · see citing works

Spectroscopic and thermodynamic interaction studies of anti-diabetic drug with globular proteins

(2019) · Biointerface Research in Applied Chemistry · doi:10.33263/briac94.172176 · Cited by 5 · see citing works

Identification of cluster of proteins in the network of MAPK pathways as cancer drug targets

Aksam, V. K. M., Chandrasekaran, V. M., & Pandurangan, S. (2017) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2017.07.001 · Cited by 5 · see citing works

Abuse liability assessment for biologic drugs – All molecules are not created equal

de Zafra, C. L. Z., Markgraf, C. G., Compton, D. M., & Hudzik, T. J. (2017) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2017.11.019 · Cited by 5 · see citing works

Networks and Pathways in Systems Pharmacology

Bezerianos, A., Dragomir, A., & Balomenos, P. (2017) · SpringerBriefs in computer science · doi:10.1007/978-3-319-53868-6_2 · Cited by 4 · see citing works

Synthesis of imatinib, a tyrosine kinase inhibitor, labeled with carbon‐14

Kang, J., Lee, J. Y., Park, J. H., & Chang, D. (2020) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3830 · Cited by 4 · see citing works

AI-driven parametrization of Michaelis–Menten maximal velocity: Advancing in silico new approach methodologies (NAMs)

Karakoltzidis, A., Karakitsios, S., & Sarigiannis, D. A. (2025) · NAM journal. · doi:10.1016/j.namjnl.2025.100012 · Cited by 3 · see citing works

Anti-amyloid drug design

Banach, M., Konieczny, L., & Roterman, I. (2019) · Elsevier eBooks · doi:10.1016/b978-0-08-102981-7.00019-1 · Cited by 3 · see citing works

Relating drug–protein interaction network with drug side effects

Mizutani, S., Pauwels, E., Stoven, V., Goto, S., & Yamanishi, Y. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts383 · Cited by 211 · see citing works

Curated and Structure-Based Drug–Target Interactions Improve Underprediction of Drug Side Effects in Network Models

Alidoost, M., Le, A., & Wilson, J. L. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c01822 · Cited by 1 · see citing works

Network‐based method to infer the contributions of proteins to the etiology of drug side effects

Li, R., Chen, T., & Li, S. (2015) · Quantitative Biology · doi:10.1007/s40484-015-0051-0 · Cited by 1 · see citing works

Predicting therapeutic and side effects from drug binding affinities to human proteome structures

Sawada, R., Sakajiri, Y., Shibata, T., & Yamanishi, Y. (2024) · iScience · doi:10.1016/j.isci.2024.110032 · Cited by 13 · see citing works

Elucidating the druggability of the human proteome with eFindSite

Kana, O., & Brylinski, M. (2019) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-019-00197-w · Cited by 27 · see citing works